P

Inventor

ERIKSSON ULF

SE57 patents
⚠️ This page may combine multiple inventors who share the name “ERIKSSON ULF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LUDWIG INST CANCER RES

20 patents
US5840693ANov 24, 1998

Vascular endothelial growth factor-B

LUDWIG INST CANCER RES156 citations98
US5607918AMar 4, 1997

Vascular endothelial growth factor-B and DNA coding therefor

LUDWIG INST CANCER RES239 citations98
US6331301B1Dec 18, 2001

Antibodies specific for vascular endothelial growth factor-B

LUDWIG INST CANCER RES58 citations95
US5928939AJul 27, 1999

Vascular endothelial growth factor-b and dna coding therefor

LUDWIG INST CANCER RES65 citations95
US6706687B1Mar 16, 2004

Platelet-derived growth factor D

LUDWIG INST CANCER RES41 citations89
US9487579B2Nov 8, 2016

Methods and compositions for modulation of blood-neural barrier

LUDWIG INST CANCER RES3 citations80
US7709450B2May 4, 2010

Stimulation of vascularization with VEGF-B-186

LUDWIG INST CANCER RES6 citations72
US5731195AMar 24, 1998

Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with p63, a portion of a retinol binding protein receptor

LUDWIG INST CANCER RES5 citations72
US5573939ANov 12, 1996

DNA encoding mammalian retinol binding protein receptor, and corresponding vectors and transformed cells

LUDWIG INST CANCER RES13 citations69
US6262337B1Jul 17, 2001

Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B DNA) and uses thereof

LUDWIG INST CANCER RES13 citations67
US6793918B2Sep 21, 2004

In vivo stimulation of angiogenic activity

LUDWIG INST CANCER RES12 citations66
US9078877B2Jul 14, 2015

Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases

LUDWIG INST CANCER RES1 citations63
US8383112B2Feb 26, 2013

Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases

LUDWIG INST CANCER RES1 citations63
US7341996B2Mar 11, 2008

Processed vascular endothelial growth factor-B polypeptides

LUDWIG INST CANCER RES3 citations62
US7034200B2Apr 25, 2006

Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof

LUDWIG INST CANCER RES3 citations60
US6399344B1Jun 4, 2002

Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding receptors

LUDWIG INST CANCER RES3 citations58
US6280997B1Aug 28, 2001

Isolated nucleic acid molecule which codes for a 32 KDA protein having 11-CIS retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor

LUDWIG INST CANCER RES4 citations58
US7476654B2Jan 13, 2009

Method for modulating, regulating and/or stabilizing angiogenesis

LUDWIG INST CANCER RES0 citations51
US6670125B2Dec 30, 2003

Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents

LUDWIG INST CANCER RES1 citations49
US5972646AOct 26, 1999

Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor

LUDWIG INST CANCER RES0 citations48

CSL LTD

6 patents

ERIKSSON ULF

4 patents

LICENTIA LTD

3 patents

EDMESTON AB

2 patents

PARACRINE THERAPEUTICS AB

2 patents

LUDWIG INST FOR CANCER RES LTD

2 patents

MORA OF SWEDEN AB

1 patent

ERICSSON TELEFON AB L M

1 patent

SANDVIK AB

1 patent

VALMET OY

1 patent

AFFARSVERKET FFV

1 patent

FUJI AUTOTECH AB

1 patent

VEGENICS PTY LTD

1 patent

EIE MASKIN AB

1 patent

UNIV HELSINKI LICENSING

1 patent

ANDERSSON BJOERN

1 patent

HAMRA INVEST AB

1 patent

Showing the top 50 of 57 patents by PatentIndex Score.